Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chediak

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
The American Journal of Medicine|August 1, 1984
Pulmonary function in hemophiliac patients treated with commercial factor VIII concentratesJ Chediak, A Chausow, A Solarski, et al.
Chest|February 1, 1989
Antithrombotic agents in coronary artery diseaseL Resnekov, J Chediak, J Hirsh, et al.
Surgery|April 1, 1981
Surgical implications of antithrombin III deficiencyR Karl, I Garlick, C Zarins, et al.
Blood|November 1, 1980
Successful management of bleeding in a patient with factor V inhibitor by platelet transfusionsJ Chediak, J B Ashenhurst, I Garlick, et al.
Thrombosis and Haemostasis|November 1, 1991
The role of von Willebrand factor in pre-eclampsiaF Bergmann, S Rotmensch, B Rosenzweig, et al.
American Journal of Clinical Pathology|July 1, 1980
Combined severe factor XI deficiency and von Willebrand's diseaseJ Chediak, E Lambert, E I Johnson, et al.
Blood|December 1, 1983
Antithrombin "Chicago": a functionally abnormal molecule with increased heparin affinity causing familial thrombophiliaK A Bauer, J B Ashenhurst, J Chediak, et al.
Bulletin of the Menninger Clinic|September 1, 1976
Reflections on the diagnostic process by a clinical teamJ de la Torre, A Appelbaum, D J Chediak, et al.
British Journal of Haematology|September 1, 1979
Cycles of agglutination-disagglutination induced by ristocetin in thrombasthenic plateletsJ Chediak, M C Telfer, B Vander Laan, et al.
Thrombosis and Haemostasis|October 29, 1982
Human plasminogen variant Chicago IIIR C Wohl, L Summaria, J Chediak, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The American Journal of Medicine|August 1, 1984
Pulmonary function in hemophiliac patients treated with commercial factor VIII concentratesJ Chediak, A Chausow, A Solarski, et al.
Chest|February 1, 1989
Antithrombotic agents in coronary artery diseaseL Resnekov, J Chediak, J Hirsh, et al.
Surgery|April 1, 1981
Surgical implications of antithrombin III deficiencyR Karl, I Garlick, C Zarins, et al.
Blood|November 1, 1980
Successful management of bleeding in a patient with factor V inhibitor by platelet transfusionsJ Chediak, J B Ashenhurst, I Garlick, et al.
Thrombosis and Haemostasis|November 1, 1991
The role of von Willebrand factor in pre-eclampsiaF Bergmann, S Rotmensch, B Rosenzweig, et al.
American Journal of Clinical Pathology|July 1, 1980
Combined severe factor XI deficiency and von Willebrand's diseaseJ Chediak, E Lambert, E I Johnson, et al.
Blood|December 1, 1983
Antithrombin "Chicago": a functionally abnormal molecule with increased heparin affinity causing familial thrombophiliaK A Bauer, J B Ashenhurst, J Chediak, et al.
Bulletin of the Menninger Clinic|September 1, 1976
Reflections on the diagnostic process by a clinical teamJ de la Torre, A Appelbaum, D J Chediak, et al.
British Journal of Haematology|September 1, 1979
Cycles of agglutination-disagglutination induced by ristocetin in thrombasthenic plateletsJ Chediak, M C Telfer, B Vander Laan, et al.
Thrombosis and Haemostasis|October 29, 1982
Human plasminogen variant Chicago IIIR C Wohl, L Summaria, J Chediak, et al.
Pageof 4